Delivery Order SPE2DB24D2018-SPE2DB25FWVS7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Zepbound 5 mg/0.5 ml pens valued at $3,647.57. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's broader Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $67,987.81 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on July 22, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $20,902.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This contract, which carries an ultimate completion date of July 28, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order was competitively awarded without set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $5,571.20 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pen injectors. The contract was awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, and utilizes firm fixed price pricing with no set-aside designation. This delivery order represents a competitively awarded transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,702.33 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injectors. This firm fixed price, non-set-aside delivery order is scheduled for completion by July 24, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $11,640.30 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pens. This firm fixed-price contract, which is a child order under a larger contract vehicle, will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $14,661.49 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 ml pen injectors on July 23, 2025. This firm fixed-price delivery order is non-competitive and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with completion scheduled for July 24, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $26,993.06 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,575.56 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and designates Conshohocken, Pennsylvania as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,143.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injectors. The order, which represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, is scheduled for completion by July 22, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWVS7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,311.50 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on July 21, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company maintains an extensive portfolio of pharmaceutical deliveries through the DLA Medical Supply Chain, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Zepbound, a diabetes and weight management medication, exemplifies the company's role in providing specialized pharmaceutical products to support Defense Health Agency and broader federal healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.3k | 7/21/25 |